Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Humana sues U.S. government to block Medicare clawback rule

Published 09/05/2023, 11:02 AM
Updated 09/05/2023, 11:06 AM
© Reuters. FILE PHOTO: Signage for Humana Inc. is pictured at a health facility in Queens, New York City, U.S., November 30, 2021. REUTERS/Andrew Kelly
HUM
-

By Jonathan Stempel

(Reuters) -Humana on Friday sued the U.S. government to block a Biden administration policy allowing Medicare to claw back billions of dollars from insurers for overcharges.

The lawsuit in federal court said the Centers for Medicare and Medicaid Services "did not even try" to justify its more aggressive approach toward determining whether private Medicare Advantage plans for people aged 65 and older were overpaid.

Humana objected to a rule announced on Jan. 30 to let the government recoup payments when audits uncover charges for diagnoses that are not in patients' medical records.

The insurer said the rule, which would apply retroactively, was "arbitrary and capricious," and threatened "unpredictable consequences for Medicare Advantage organizations and the millions of seniors who rely on the Medicare Advantage program for their healthcare."

Close to half of the approximately 65 million Medicare enrollees sign up for Medicare Advantage.

The Biden administration has said the crackdown could help the government collect as much as $4.7 billion over 10 years.

CMS, part of the U.S. Department of Health and Human Services, said in an email it does not discuss pending litigation.

Medicare Advantage plans differ from traditional Medicare because private companies offer them, and are reimbursed by the government for care.

Congress authorized the plans in 2003 as a means to encourage better healthcare at lower cost.

In announcing the rule, HHS Secretary Xavier Becerra called it "long overdue," citing federal watchdogs and outside experts who for many years had lamented Medicare's failure to crack down on overcharging.

The rule relates to a system of "risk adjustment" in which, for example, payments would be lower for healthier patients who might be expected to incur lower medical bills.

But Humana said CMS had more than a decade ago rejected the documentation standards required under the rule, and its "about-face" was unfair to insurers that relied on its prior practices.

Though Humana is based in Louisville, Kentucky, it filed its lawsuit with the U.S. District Court in the Northern District of Texas.

That court has in recent years been sympathetic toward some challenges to federal rulemaking.

© Reuters. FILE PHOTO: Signage for Humana Inc. is pictured at a health facility in Queens, New York City, U.S., November 30, 2021. REUTERS/Andrew Kelly

The case was assigned to U.S. District Judge Reed O'Connor, a Fort Worth judge who previously declared unconstitutional all or part of the Affordable Care Act, also known as Obamacare.

The case is Humana Inc (NYSE:HUM) et al v Becerra et al, U.S. District Court, Northern District of Texas, No. 23-00909.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.